The launch of the Catalyst® Pancreatic Lipase Test demonstrates IDEXX's Technology for Life strategy and will provide veterinarians with quantitative results at the point-of-care in less than 10 ...
WESTBROOK, Maine, Jan. 13, 2014 /PRNewswire/ -- IDEXX Laboratories, Inc. announces a significant new addition to its leading line of point-of-care instruments, the Catalyst One(TM) Chemistry Analyzer.
Addison's disease, often called "the great pretender," is a life-threatening condition caused by low cortisol and is difficult to diagnose due to its common and nonspecific clinical signs that can ...
Q3 2025 Earnings Call Transcript November 3, 2025 IDEXX Laboratories, Inc. beats earnings expectations. Reported EPS is $3.4, ...
The Catalyst® Cortisol Test provides veterinarians with real-time critical insights when evaluating dogs for Addison's disease and Cushing's syndrome "The Catalyst Cortisol Test is an accurate and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback